NFKB1 and colon carcinoma: Experimental data from Tong et al. demonstrate that curcumin-mediated AMP-activated protein kinase (AMPK) activation inhibits metastatic progression in colon carcinoma through transcriptional suppression of p65 NF-κB, urokinase plasminogen activator (uPA), and MMP9 [53].